Akebia Therapeutics plans public offering of common stock

From GlobeNewswire: 2025-03-19 16:01:00

Akebia Therapeutics, Inc. has announced the commencement of an underwritten public offering. All shares are being offered by Akebia and the underwriters may have an option to purchase additional shares. Leerink Partners and Piper Sandler & Co. are acting as joint bookrunning managers for the Offering. The shares are being offered pursuant to a shelf registration statement filed with the SEC. A preliminary prospectus supplement will be filed with the SEC, and final terms of the Offering will be disclosed in a final prospectus supplement. This press release does not constitute an offer to sell securities. Akebia Therapeutics is a biopharmaceutical company focused on kidney disease.



Read more at GlobeNewswire: Akebia Therapeutics Announces Proposed Public Offering of